Table 1.
Comparison of clinical and laboratory parameters of the patients participating in the study
| Total (n:200) | MHD (n:157) | CAPD (N:43) | p* value | |
|---|---|---|---|---|
| Age, year | 61.3 ± 13.7 | 61.8 ± 13.6 | 59.4 ± 13.9 | 0.291 |
| Gender (F/M) | 88/112 | 63/94 | 25/18 | 0.035 |
| Duration of dialysis, months | 32 (6–291) | 39(6–291) | 15(7–168) | 0.001 |
| Urea, mg/dl | 122.2 ± 37 | 121.9 ± 37.4 | 123.1 ± 36.1 | 0.853 |
| Creatinine, mg/dl | 7.8 ± 2.6 | 7.7 ± 2.6 | 8 ± 2.4 | 0.404 |
| Calcium,mg/dl | 8.5 ± 0.8 | 8.6 ± 0.7 | 8.4 ± 1.1 | 0.255 |
| Phosphorus,mg/dl | 5.1 ± 1.2 | 5.1 ± 1.2 | 4.9 ± 1.3 | 0.458 |
| Albumin, g/dl | 3.5 ± 0.5 | 3.5 ± 0.5 | 3.3 ± 0.5 | 0.911 |
| Ferritin | 405 (28–2000) | 420(28–2000) | 405(44–2000) | 0.913 |
| Hemoglobin | 10.7 ± 1.3 | 10.7 ± 1.3 | 11.1 ± 1.4 | 0.089 |
| CRP, g/L | 7 (0.4–348) | 8(0.4–348) | 8(3–149) | 0.678 |
p value < 0.05 is significant statistically and was shown as bold
*p-value belongs to hemodialysis and CAPD patients